Event Recordings

Day 1  |  Day 2

Day 2: Tuesday, April 30, 2024

Session VI: Academia to Industry and Back

Moderators: Yevgeniya Nusinovich, MD, PhD (Senior Editor, Science) and Sanjay Malhotra, PhD (Professor, Oregon Health & Science University)

Session IV Full Recording

Designer DNA Drug Therapy for Neurodegenerative Disease

Don Cleveland, PhD
Department Chair, Cellular and Molecular Medicine (CMM); Professor, Cellular and Molecular Medicine, University of California San Diego

Toward Universal Druggability

Gregory Verdine, PhD
Erving Professor of Chemistry, Harvard University

Drug Discovery at Fred Hutch Cancer Center

Thomas Lynch, MD
President and Director, Fred Hutchinson Cancer Center

Session VI Panel Discussion

Session VIII: Drug Discovery II: Core Principles and Frontiers

Moderators: Fady Malik, MD, PhD (Executive Vice President of Research and Development, Cytokinetics) and Mark Mercola, PhD (Professor, Stanford University School of Medicine)

Session VIII Full Recording

Discovery of an Orally Bioavailable Macrocyclic PCSK9 Inhibitor

George Addona, PhD
Senior Vice President and Head, Discovery, Preclinical Development, and Translational Medicine, Merck Research Laboratories

Data & Patients: Novel Partners in Drug Development

Paul Burton, MD, PhD
Senior Vice President and Chief Medical Officer, Amgen

Plaiting The Golden Braid: Incorporating Patient-Generated Data In Clinical Development

Andrew Trister, MD, PhD
Chief Medical Officer and Chief Scientific Officer, Verily Life Sciences

Future Advances in the Treatment of Neuromuscular Disorders

Paulo Fontoura, MD, PhD
Global Head and Senior Vice President of Neuroscience, Immunology, Ophthalmology, and Rare Diseases, Roche

Session VIII Panel Discussion

Session IX: Perspectives and Opportunities in Translational Research and Therapeutics

Moderators: Carolyn Bertozzi, PhD (Baker Family Director of Stanford ChEM-H, Anne T. and Robert M. Bass Professor, Stanford University), and Kuldev Singh, MD (Professor, Stanford University School of Medicine)

Session IX Full Recording

Delivering on the Promise of Genetic Medicines

Peter Marks, MD, PhD
Director, Center for Biologics Evaluation and Research, Food and Drug Administration

Advances and Innovations in CDER’s Approach to Drug Development

Patrizia Cavazzoni, MD
Director, Center for Drug Evaluation and Research, Food and Drug Administration

Update on CIRM Funding Programs

Rosa Canet-Avilés, PhD
Vice President, Scientific Programs & Education, California Institute for Regenerative Medicine

Translational Science: Maximizing the Success of Therapeutic Development

Joni Rutter, PhD
Director, National Center for Advancing Translational Sciences, National Institutes of Health

AI and Drug Discovery @ ARPA-H

Wade Shen
Director of Proactive Health Office, Advanced Research Projects Agency for Health (ARPA-H)

Session IX Panel Discussion